These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1648 related items for PubMed ID: 9743347

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Vesnarinone suppresses TNF-induced activation of NF-kappa B, c-Jun kinase, and apoptosis.
    Manna SK, Aggarwal BB.
    J Immunol; 2000 Jun 01; 164(11):5815-25. PubMed ID: 10820260
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Silymarin suppresses TNF-induced activation of NF-kappa B, c-Jun N-terminal kinase, and apoptosis.
    Manna SK, Mukhopadhyay A, Van NT, Aggarwal BB.
    J Immunol; 1999 Dec 15; 163(12):6800-9. PubMed ID: 10586080
    [Abstract] [Full Text] [Related]

  • 5. Immunosuppressive leflunomide metabolite (A77 1726) blocks TNF-dependent nuclear factor-kappa B activation and gene expression.
    Manna SK, Aggarwal BB.
    J Immunol; 1999 Feb 15; 162(4):2095-102. PubMed ID: 9973483
    [Abstract] [Full Text] [Related]

  • 6. Leflunomide suppresses TNF-induced cellular responses: effects on NF-kappa B, activator protein-1, c-Jun N-terminal protein kinase, and apoptosis.
    Manna SK, Mukhopadhyay A, Aggarwal BB.
    J Immunol; 2000 Nov 15; 165(10):5962-9. PubMed ID: 11067959
    [Abstract] [Full Text] [Related]

  • 7. IFN-alpha suppresses activation of nuclear transcription factors NF-kappa B and activator protein 1 and potentiates TNF-induced apoptosis.
    Manna SK, Mukhopadhyay A, Aggarwal BB.
    J Immunol; 2000 Nov 01; 165(9):4927-34. PubMed ID: 11046018
    [Abstract] [Full Text] [Related]

  • 8. Differential requirement for p56lck in HIV-tat versus TNF-induced cellular responses: effects on NF-kappa B, activator protein-1, c-Jun N-terminal kinase, and apoptosis.
    Manna SK, Aggarwal BB.
    J Immunol; 2000 May 15; 164(10):5156-66. PubMed ID: 10799874
    [Abstract] [Full Text] [Related]

  • 9. Thalidomide suppresses NF-kappa B activation induced by TNF and H2O2, but not that activated by ceramide, lipopolysaccharides, or phorbol ester.
    Majumdar S, Lamothe B, Aggarwal BB.
    J Immunol; 2002 Mar 15; 168(6):2644-51. PubMed ID: 11884428
    [Abstract] [Full Text] [Related]

  • 10. Overexpression of gamma-glutamylcysteine synthetase suppresses tumor necrosis factor-induced apoptosis and activation of nuclear transcription factor-kappa B and activator protein-1.
    Manna SK, Kuo MT, Aggarwal BB.
    Oncogene; 1999 Jul 29; 18(30):4371-82. PubMed ID: 10439045
    [Abstract] [Full Text] [Related]

  • 11. Oleandrin suppresses activation of nuclear transcription factor-kappaB, activator protein-1, and c-Jun NH2-terminal kinase.
    Manna SK, Sah NK, Newman RA, Cisneros A, Aggarwal BB.
    Cancer Res; 2000 Jul 15; 60(14):3838-47. PubMed ID: 10919658
    [Abstract] [Full Text] [Related]

  • 12. Alpha-melanocyte-stimulating hormone inhibits the nuclear transcription factor NF-kappa B activation induced by various inflammatory agents.
    Manna SK, Aggarwal BB.
    J Immunol; 1998 Sep 15; 161(6):2873-80. PubMed ID: 9743348
    [Abstract] [Full Text] [Related]

  • 13. Suppression of tumor necrosis factor-activated nuclear transcription factor-kappaB, activator protein-1, c-Jun N-terminal kinase, and apoptosis by beta-lapachone.
    Manna SK, Gad YP, Mukhopadhyay A, Aggarwal BB.
    Biochem Pharmacol; 1999 Apr 01; 57(7):763-74. PubMed ID: 10075082
    [Abstract] [Full Text] [Related]

  • 14. Wortmannin inhibits activation of nuclear transcription factors NF-kappaB and activated protein-1 induced by lipopolysaccharide and phorbol ester.
    Manna SK, Aggarwal BB.
    FEBS Lett; 2000 May 04; 473(1):113-8. PubMed ID: 10802070
    [Abstract] [Full Text] [Related]

  • 15. NF-kappa B-inducing kinase is a common mediator of IL-17-, TNF-alpha-, and IL-1 beta-induced chemokine promoter activation in intestinal epithelial cells.
    Awane M, Andres PG, Li DJ, Reinecker HC.
    J Immunol; 1999 May 01; 162(9):5337-44. PubMed ID: 10228009
    [Abstract] [Full Text] [Related]

  • 16. Adenosine suppresses activation of nuclear factor-kappaB selectively induced by tumor necrosis factor in different cell types.
    Majumdar S, Aggarwal BB.
    Oncogene; 2003 Feb 27; 22(8):1206-18. PubMed ID: 12606947
    [Abstract] [Full Text] [Related]

  • 17. Ceramide inhibits lipopolysaccharide-mediated nitric oxide synthase and cyclooxygenase-2 induction in macrophages: effects on protein kinases and transcription factors.
    Hsu YW, Chi KH, Huang WC, Lin WW.
    J Immunol; 2001 May 01; 166(9):5388-97. PubMed ID: 11313375
    [Abstract] [Full Text] [Related]

  • 18. Antioxidants differentially regulate activation of nuclear factor-kappa B, activator protein-1, c-jun amino-terminal kinases, and apoptosis induced by tumor necrosis factor: evidence that JNK and NF-kappa B activation are not linked to apoptosis.
    Shrivastava A, Aggarwal BB.
    Antioxid Redox Signal; 1999 May 01; 1(2):181-91. PubMed ID: 11228746
    [Abstract] [Full Text] [Related]

  • 19. Protein tyrosine kinase inhibitors block tumor necrosis factor-induced activation of nuclear factor-kappaB, degradation of IkappaBalpha, nuclear translocation of p65, and subsequent gene expression.
    Natarajan K, Manna SK, Chaturvedi MM, Aggarwal BB.
    Arch Biochem Biophys; 1998 Apr 01; 352(1):59-70. PubMed ID: 9521814
    [Abstract] [Full Text] [Related]

  • 20. Bcl-x(L) suppresses TNF-mediated apoptosis and activation of nuclear factor-kappaB, activation protein-1, and c-Jun N-terminal kinase.
    Manna SK, Haridas V, Aggarwal BB.
    J Interferon Cytokine Res; 2000 Aug 01; 20(8):725-35. PubMed ID: 10954916
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 83.